Publication Name	World Journal of Methodology
Manuscript ID	76205
Country	Hungary

Received	2022-03-07 13:53
Peer-Review Started	2022-03-07 13:54
To Make the First Decision
Return for Revision	2022-04-12 09:29
Revised	2022-04-22 13:11
Second Decision	2022-07-11 02:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-07-11 18:03
Articles in Press	2022-07-11 18:03
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-07-04 16:47
Typeset the Manuscript	2022-07-12 07:36
Publish the Manuscript Online	2022-07-20 07:37

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Reinfection, recontamination and revaccination for SARS-CoV-2
Manuscript Source	Invited Manuscript
All Author List	Tamás Kullmann and András Drozgyik
ORCID	Author(s) ORCID Number Tamás Kullmann http://orcid.org/0000-0002-8324-1971
Funding Agency and Grant Number
Corresponding Author	Tamás Kullmann, PhD, Consultant Physician-Scientist, Department of Medical Emergencies, Petz Aladár Hospital, Vasvári Pál u. 2-4, Győr 9024, Hungary. kullmanndoki@gmail.com
Key Words	SARS-CoV-2; COVID-19; Polymerase Chain Reaction; Immunisation; Contamination; Vaccination
Core Tip	Reinfection: There is not enough evidence of the protective efficacy of the natural im-munity induced by a primary infection with severe acute coronavirus 2 (SARS-CoV-2). Recontamination: Testing positive for a second time for SARS-CoV-2 does not neces-sarily mean a reinfection; it can also be interpreted as recontamination. Revaccination: The available evidence may suggest that the protective value of a prior infection could be better considered for vaccine distribution in the future.
Publish Date	2022-07-20 07:37
Citation	Kullmann T, Drozgyik A. Reinfection, recontamination and revaccination for SARS-CoV-2. World J Methodol 2022; 12(4): 258-263
URL	https://www.wjgnet.com/2222-0682/full/v12/i4/258.htm
DOI	https://dx.doi.org/10.5662/wjm.v12.i4.258

Full Article (PDF)	WJM-12-258.pdf
Full Article (Word)	WJM-12-258.docx
Manuscript File	76205_Auto_Edited-LM.docx
Answering Reviewers	76205-Answering reviewers.pdf
Audio Core Tip	76205-Audio core tip.aac
Conflict-of-Interest Disclosure Form	76205-Conflict-of-interest statement.pdf
Copyright License Agreement	76205-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	76205-Language certificate.pdf
Peer-review Report	76205-Peer-review(s).pdf
Scientific Misconduct Check	76205-Bing-Liu JH-2.jpg
Scientific Misconduct Check	76205-CrossCheck.jpg
Scientific Editor Work List	76205-Scientific editor work list.pdf